Gilead to acquire Myogen
423442
Gilead Sciences Inc. , the world's third-biggest biotechnology company, said on Monday it has agreed to acquire Myogen Inc.  for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs.
627268
By Sharon Smyth  Merck, the German pharmaceutical company that failed to buy a rival, Schering, this year, agreed to buy the stake owned by the billionaire Ernesto Bertarelli in Serono to obtain control of the largest biotechnology company in Europe.
113587
Gilead Sciences Inc.  said on  Monday it will acquire Myogen Inc.  for $2.5 billion,  gaining control of Myogen's experimental heart medicines.
580086
WASHINGTON (CBS.MW) -- Mylan Laboratories (MYL) , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals (KG) is in the long-term interest of the generic drugmaker and its
155787
Bristol-Myers Squibb (NYSE: BMY) and Gilead Sciences (Nasdaq: GILD) have taken a much-needed step that should make patients&#39; lives easier even as it improves the companies&#39; results.
306497
Gilead Sciences Inc. , one of the world's biggest biotechnology companies, said on Monday it agreed to acquire tiny Myogen Inc.  for $2.5 billion to gain control of its promising hypertension drugs.
294153
Britain's Shire Plc  has agreed to buy U.S. partner New River Pharmaceuticals  for $2.6 billion to gain full control of the two firms' new drug for attention deficit hyperactivity disorder (ADHD), Vyvanse.
451417
Gilead announces its fourth-quarter financial results.
434440
Houghton Mifflin Riverdeep Groupâs agreement to acquire the United States educational business of the Harcourt division of Reed Elsevier is the latest in a series of deals that have transformed educational publishing.
751523
A new addition to an already successful drug promises good results for investors.
97416
THE REGION Cambridge Drug maker Biogen Idec Inc. said it would start buying $3 billion worth of its own shares, potentially cutting the number of outstanding shares by one-sixth. Chief executive James Mullen said strong cash flows from sales of Avonex, for multiple sclerosis, and Rituxan, for non-Hodgkin's lymphoma, allowed the company to return money to shareholders in a tender ...
331749
Not buying it. Megafinancier Carl Icahn has made it clear: He&#39;s still opposed to Mylan Laboratories&#39; (nyse: MYL - news - people ) proposed acquisition of King Pharmaceuticals (nyse: KG - news - people ). Despite
530724
Orthopedic device maker Biomet Inc.   said on Monday it has agreed to be acquired by a  private equity consortium for about $10.9 billion.
327285
Drug and nutritional products maker Perrigo Co. is buying pharmaceutical company Agis Industries Ltd. for about $818 million as part of its effort to expand into the generic prescription drug market.
483525
Biomet, a major manufacturer of artificial hips and knees, said Monday that it had agreed to be acquired by a private investment consortium.
536259
Genzyme Corp.'s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug Administration recommended the agency approve Ilex's experimental cancer treatment for children with certain types of leukemia.
142092
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in after-hours trading Tuesday after Tysabri, a drug used for the treatment of multiple sclerosis, was approved by the US Food and Drug Administration.